Showing results (171-180 of 403) with videos related to
Sort By:
Pageof 41
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1986
Increased expression of p53 protein in human leukemia cellsH P Koeffler, C Miller, M A Nicolson, et al.Molecular Carcinogenesis|August 1, 1997
Integrity of the 1,25-dihydroxyvitamin D3 receptor in bone, lung, and other cancersC W Miller, R Morosetti, M J Campbell, et al.Cancer Research|August 27, 1999
5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cellsJ Hisatake, T Kubota, Y Hisatake, et al.Pediatric Research|October 1, 1996
Production of interleukin-10 in the cerebrospinal fluid in aseptic meningitis of childrenA Ishiguro, Y Suzuki, Y Inaba, et al.Cancer Research|August 12, 1998
19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cellsT Kubota, K Koshizuka, M Koike, et al.Blood|August 1, 1980
An undifferentiated variant derived from the human acute myelogenous leukemia cell line (KG-1)H P Koeffler, R Billing, A J Lusis, et al.The Journal of Clinical Investigation|January 1, 1990
Role of lymphotoxin in expression of interleukin 6 in human fibroblasts. Stimulation and regulationM Akashi, A H Loussararian, D C Adelman, et al.The American Journal of Pathology|December 1, 1992
Immunohistochemical analysis of p53 expression in malignant lymphomasJ W Said, R Barrera, I P Shintaku, et al.Cancer Research|June 13, 2000
Allelic loss in the progression of myelodysplastic syndromeN Mori, R Morosetti, E Hoflehner, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 1, 1994
p53 mutations and MDM-2 amplification in renal cell cancersY Imai, T G Strohmeyer, M Fleischhacker, et al.Pageof 41